Nigeria News | NAFDAC Recalls Infants’ Ibuprofen Concentrated Oral Suspension

Image Credit: NLIPW

According to the National Agency for Food and Drug Administration and Control (NAFDAC), the agency was reportedly informed that Spanish drug manufacturer, Tris Pharma, voluntary recalled one lot of Ibuprofen Concentrated Oral Suspension due to potentially high concentrations of the drug.

Ibuprofen Oral Suspension is a Nonsteroidal Anti-Inflammatory Drug (NSAID) typically used to treat fever or pain. It is also used to relieve discomfort from teething and ear infections. It is generally safe when taken as directed by physician. However, excessive doses of Ibuprofen can be very dangerous, especially in infants who may be more susceptible to higher potency of the drug which can cause renal injury.

Details of additional Ibuprofen oral suspension being recalled are:

471859779-925-2312/19CVS Health: infants ibuprofen concentrated oral suspension, USP; 50mg per 1.25ml, in o.5 oz. bottle CVS Pharm

NAFDAC is asking all importers, wholesalers and retailers to immediately stop the importation, distribution and sale of the product while advising health care providers and members of the public to stop the administration and use of the affected products to avoid negative health implications.

Print Friendly, PDF & Email
About Nathaniel Adebayo 734 Articles
Nathaniel is a News Reporting Intern at Nigerian Law Intellectual Property Watch (NLIPW). He has a passion for writing, capacity building and social media marketing. He is a graduate of Federal University of Technology, Minna, where he graduated with BTECHAGRIC. He is a member of Soil Science Society of Nigeria (SSSN) and the National Union of Campus Journalist (NUCJ). Nathaniel has served as Editor-in-Chief for a number of magazines and as a contributor to various online repositories. Email: